ELUCIDATING THE ROLE OF VERY-LONG-CHAIN POLYUNSATURATED FATTY ACIDS IN RETINAL HEALTH AND DISEASE

UNIVERSITY OF UTAH VISION RESEARCH CORE GRANT

PHASE 3 MULTICENTER RANDOMIZED DOUBLE-MASKED PLACEBO-CONTROLLED STUDY TO EVALUATE SAFETY AND EFFICACY OF TINLAREBANT IN TREATMENT OF STARGARDT DISEASE IN ADOLESCENT SUBJECTS

A PHASE 2B, RANDOMIZED, DOUBLE-MASKED, MULTICENTER, DOSE-RANGING, SHAM-CONTROLLED TRIAL TO EVALUATE INTRAVITREAL JNJ-81201887 (AAVCAGSCD59) COMPARED TO SHAM PROCEDURE TO TREAT GEOGRAPHIC ATROPHY (GA) SECONDARY TO AGE-RELATED MACULAR DEGENERATION (AMD)

UNIVERSAL RARE GENE STUDY: A REGISTRY AND NATURAL HISTORY STUDY OF RETINAL DYSTROPHIES ASSOCIATED WITH RARE DISEASE-CAUSING GENETIC VARIANTS

PHASE 1/2A DOSE ESCALATION SAFETY STUDY OF VOY-101 IN SUBJECTS WITH ADVANCED NON-EXUDATIVE AGE-RELATED MACULAR DEGENERATION

CHANGES IN FLUORESCENCE LIFETIME IMAGING OPHTHALMOSCOPY AND DESCRIPTION OF HIGH-RESOLUTION OCT FINDINGS IN PATIENTS WHO PREVIOUSLY DID AND DID NOT HAVE HYDROXYCHLOROQUINE TOXICITY (SPENCER FULLER PI)

PHASE III, MULTICENTER, RANDOMIZED, PARALLEL, AND PLACEBO-CONTROLLED STUDY THAT EVALUATES THE EFFICACY AND SAFETY OF ORAL N-ACETYLCYSTEINE (NAC) IN PATIENTS WITH RETINITIS PIGMENTOSA (RP).

PHASE 2A STUDY OF THE EFFECT OF SERINE SUPPLEMENTATION AND FENOFIBRATE TREATMENT ON SERUM DEOXYSPHINGANINE LEVELS IN PATIENTS WITH MACULAR TELANGIECTASIA (MACTEL) TYPE 2

BIOCHEMISTRY AND PHARMACOLOGY OF THE MACULAR CAROTENOIDS

A PHASE 2 STUDY OF THE VALUE OF PRE-SYMPTOMATIC GENETIC RISK ASSESSMENT FOR AGE-RELATED MACULAR DEGENERATION

A RANDOMIZED, PARTIALLY MASKED, CONTROLLED, PHASE 2B/3 CLINICAL STUDY TO EVALUATE EFFICACY AND SAFETY OF RGX-314 GENE THERAPY IN PARTICIPANTS WITH NAMD

ADAPTIVE OPTICS FLUORESCENCE LIFETIME OPTHALMOSCOPY (AOFLIO) IN HEALTHY PEOPLE WITH DISEASE

CORNEAL NERVE FIBER ABNORMALITIES IN PATIENTS W MACULAR TELANGIECTASIA TYPE 2 (MACTEL) AND HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 1 (HSAN1)

PHASE 3, OPEN-LABEL, MULTICENTER, EXTENSION STUDY TO EVALUATE LONG-TERM SAFETY AND EFFICACY OF PEGCETACOPLAN IN SUBJECTS WITH GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION

TESSERACT IC

OPEN LABEL PHASE 1/2 TRIAL OF GENE THERAPY 4D-125 IN MALES WITH X-LINKED RETINITIS PIGMENTOSA (XLRP) CAUSED BY MUTATIONS IN THE RPGR GENE

CORE GRANT

PHASE 1 OPEN-LABEL, DOSE-ESCALATION STUDY OF SAFETY, TOLERABILITY AND PRELIMINARY EFFICACY OF INTRAVITREAL 4D-110 IN PATIENTS WITH CHOROIDEREMIA

NATURAL HISTORY OF THE PROGRESSION OF X-LINKED RETINITIS PIGMENTOSA

VLC-PUFAS TREAT FOR STGD3

CAROTENOID SUPPLEMENTATION

MYRETINA TRACKER GENETIC TESTING STUDY

ACUCELA VCD-001

DIETARY FACTORS-RETINAL AGING